TABLE 5.
Dependent variable | Independent (explanatory) variable | Regression coefficient | 95% CI | P |
---|---|---|---|---|
BMI (kg/m2) | MM versus placebo | −0.082 | −0.285, 0.122 | 0.43 |
Female versus male | 3.031 | 2.049, 4.013 | <0.001 | |
Age <40 y | −2.661 | −3.634, −1.688 | <0.001 | |
HIV | −1.172 | −1.921, −0.422 | 0.002 | |
Hygiene score <5 | 0.135 | 0.051, 0.218 | 0.002 | |
Initial BMI <18.5 | −4.592 | −6.011, −3.173 | <0.001 | |
Midupper arm circumference (cm) | MM versus placebo | 0.0354 | −0.287, 0.358 | 0.83 |
Female versus male | 1.479 | 0.667, 2.290 | <0.001 | |
Age <40 y | 0.070 | 0.041, 0.098 | <0.001 | |
HIV | −0.953 | −1.685, −0.222 | 0.01 | |
Hygiene score <5 | 0.218 | 0.099, 0.337 | <0.001 | |
Initial BMI <18.5 | −4.395 | −5.562, −3.227 | <0.001 | |
Fat body mass (kg) | MM versus placebo | 0.113 | −0.490, 0.716 | 0.71 |
Female versus male | 8.147 | 6.383, 9.911 | <0.001 | |
Age <40 y | 0.335 | 0.273, 0.398 | <0.001 | |
HIV stage | −0.969 | −1.795, −0.143 | 0.02 | |
Initial BMI <18.5 | −5.227 | −7.703, −2.750 | <0.001 | |
Lean body mass (kg) | MM versus placebo | 0.117 | −0.584, 0.819 | 0.74 |
Female versus male | −7.989 | −9.538, −6.6441 | <0.001 | |
Age <40 y | −0.116 | −0.170, −0.063 | <0.001 | |
Hygiene score <5 | 0.594 | 0.343, 0.845 | <0.001 | |
Initial BMI <18.5 | −5.104 | −7.305, −2.903 | <0.001 | |
Grip strength (kg) | MM versus placebo | −0.026 | −0.751, 0.698 | 0.943 |
Female versus male | −7.020 | −8.204, −5.834 | <0.001 | |
Age <40 y | −0.127 | −0.169, −0.086 | <0.001 | |
HIV stage | −1.508 | −2.280, −0.734 | <0.001 | |
Hygiene score < 5 | 0.370 | 0.143, 0.596 | <0.001 |
Time series regression models were constructed to analyze the contributions of various factors (including treatment allocation) to time trends in the dependent variables shown. Final regression models are shown for each dependent variable, and treatment allocation is included even when not significant because this was the primary hypothesis being examined. MM, multiple micronutrient.